[Postoperative infections due to Pseudomonas aeruginosa].
Ishikawa
S
S
1st Department of Surgery, Nagoya City University, Medical School.
Yura
J
J
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology; D004203:Disinfection; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000382:microbiology* / Q000517:prevention & control / Q000628:therapy; D011292:Premedication; D011552:Pseudomonas Infections / Q000382:microbiology* / Q000517:prevention & control / Q000628:therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D005719:gamma-Globulins / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D005719:gamma-Globulins; D004917:Erythromycin